Evidence map›Paper›PMID 40134842›Full record

ArticleWorld journal of virology2025

Serological surveillance for SARS-CoV-2 antibodies among students, faculty and staff within a large university system during the pandemic.

Marcos G Pinheiro, Gabriela G O Alves, Maria Eduarda R Conde, Sofia L Costa, Regina C S Sant'Anna, Isa M F Antunes, Mônica C Carneiro, Fabio S Ronzei, Julia C Scaffo, Felipe R Pinheiro and 11 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Marcos G PinheiroLaboratory of Molecular Epidemiology and Biotechnology, Rodolpho Albino University Laboratory, Fluminense Federal University, Niterói 24241000, Rio de Janeiro, Brazil.
Gabriela G O AlvesLaboratory of Molecular Epidemiology and Biotechnology, Rodolpho Albino University Laboratory, Fluminense Federal University, Niterói 24241000, Rio de Janeiro, Brazil.
Maria Eduarda R CondeLaboratory of Molecular Epidemiology and Biotechnology, Rodolpho Albino University Laboratory, Fluminense Federal University, Niterói 24241000, Rio de Janeiro, Brazil.
Sofia L CostaLaboratory of Molecular Epidemiology and Biotechnology, Rodolpho Albino University Laboratory, Fluminense Federal University, Niterói 24241000, Rio de Janeiro, Brazil.
Regina C S Sant'AnnaLaboratory of Molecular Epidemiology and Biotechnology, Rodolpho Albino University Laboratory, Fluminense Federal University, Niterói 24241000, Rio de Janeiro, Brazil.
Isa M F AntunesLaboratory of Molecular Epidemiology and Biotechnology, Rodolpho Albino University Laboratory, Fluminense Federal University, Niterói 24241000, Rio de Janeiro, Brazil.
Mônica C CarneiroEstácio de Sá University, Nova Friburgo 28611135, Rio de Janeiro, Brazil.
Fabio S RonzeiEstácio de Sá University, Nova Friburgo 28611135, Rio de Janeiro, Brazil.
Julia C ScaffoLaboratory of Molecular Epidemiology and Biotechnology, Rodolpho Albino University Laboratory, Fluminense Federal University, Niterói 24241000, Rio de Janeiro, Brazil.
Felipe R PinheiroLaboratory of Molecular Epidemiology and Biotechnology, Rodolpho Albino University Laboratory, Fluminense Federal University, Niterói 24241000, Rio de Janeiro, Brazil.
Lialyz S AndreLaboratory of Molecular Epidemiology and Biotechnology, Rodolpho Albino University Laboratory, Fluminense Federal University, Niterói 24241000, Rio de Janeiro, Brazil.
Helvecio C PovoaHealth Institute of Nova Friburgo, Fluminense Federal University, Nova Friburgo 28613001, Rio de Janeiro, Brazil.
Valéria T BaltarDepartment of Epidemiology and Biostatistics, Institute of Collective Health (ISC), Fluminense Federal University, Niterói 24033900, Rio de Janeiro, Brazil.
Fabíola GiordaniHealth Institute of Nova Friburgo, Fluminense Federal University, Nova Friburgo 28613001, Rio de Janeiro, Brazil.
Eduarda S HemerlyDepartment of Epidemiology and Biostatistics, Institute of Collective Health (ISC), Fluminense Federal University, Niterói 24033900, Rio de Janeiro, Brazil.
Gisele C AlexandreDepartment of Epidemiology and Biostatistics, Institute of Collective Health (ISC), Fluminense Federal University, Niterói 24033900, Rio de Janeiro, Brazil.
Karla C de PaulaInstitute of Physical Education, Fluminense Federal University, Niterói 24020005, Rio de Janeiro, Brazil.
Márcio WatanabeDepartment of Statistics, Fluminense Federal University, Niterói 24210200, Rio de Janeiro, Brazil.
Antonio Claudio L da NóbregaDepartment of Physiology and Pharmacology, Fluminense Federal University, Niterói 24210130, Rio de Janeiro, Brazil.
Jackeline Christiane P LobatoDepartment of Epidemiology and Biostatistics, Institute of Collective Health (ISC), Fluminense Federal University, Niterói 24033900, Rio de Janeiro, Brazil.
Fabio Aguiar-AlvesPathology Program, Medicine school, Fluminense Federal University, Niterói 24070090, Rio de Janeiro, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAt the end of December 2019, the world faced severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), which led to the outbreak of coronavirus disease 2019 (COVID-19), associated with respiratory issues. This virus has shown significant challenges, especially for senior citizens, patients with other underlying illnesses, or those with a sedentary lifestyle. Serological tests conducted early on have helped identify how the virus is transmitted and how to curb its spread. The study hypothesis was that the rapid serological test for SARS-CoV-2 antibodies could indicate the immunoreactive profile during the COVID-19 pandemic in a university population.

aimTo conduct active surveillance for serological expression of anti-SARS-CoV-2 antibodies in individuals within a university setting during the COVID-19 pandemic.

methodsThis sectional study by convenience sampling was conducted in a large university in Niteroi-RJ, Brazil, from March 2021 to July 2021. The study population consisted of students, faculty, and administrative staff employed by the university. A total of 3433 faculty members, 60703 students, and 3812 administrative staff were invited to participate. Data were gathered through rapid serological tests to detect immunoglobulin (Ig) M and IgG against SARS-CoV-2. The

resultsA total of 1648 individuals were enrolled in the study. The proportion of COVID-19 positivity was 164/1648 (9.8%). The adjusted logistic model indicate a positive association between the expression of IgM or IgG and age [odds ratio (OR) = 1.16, 95%CI: 1.02-1.31] (

conclusionThese findings evidenced that the population became more exposed to the virus as individuals discontinued social distancing practices, thereby increasing the risk of infection for themselves.

Indexed as

COVID-19Risk factors for COVID-19SARS-CoV-2 antibodiesSerological rapid testSerological surveillance

Identifiers

PMID40134842
PMCPMC11612880

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.